Rallybio Corporation (RLYB) NASDAQ

5.06

+0.31(+6.53%)

Updated at February 20 04:00PM

Currency In USD

Valuation

Market Cap41.8M
Enterprise Value28.05M
P/E Ratio-2.01
PEG Ratio-0.03
Price/Sales Ratio39.64
Price/Book Ratio0.45
Enterprise/Revenue-7.72
Enterprise/EBITDA0.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-21.02
Operating Margin-56.77

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.25

Income Statement

Revenue636,000
Revenue/Share0.12
Gross Profit636,000
EBITDA-60.37M
Net Income-57.78M
Diluted EPS-10.64

Balance Sheet

Total Cash59.32M
Total Cash/Share10.53
Total Debt198,000
Total Debt/Equity0
Current Ratio14.74
Book Value Per Share11.19

Price History

52-Week Change-16.09
52-Week High6.75
52-Week Low1.76
Moving Average 50 Days5.45
Moving Average 200 Days4.33

Statistics

Average Volume22,354
Shares Outstanding5.28M
% Held by Institutions3.76

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:8
Last Split DateFebruary 06, 2026